Elypta provides the missing dynamic biological signal that unlocks risk testing at scale.
Focusing screening, surveillance and prevention on those most likely to benefit allows us to expand these life-saving interventions.
We are pioneering a metabolism-based liquid biopsy.
Our mission is to prevent cancer mortality through early detection.
We measure the GAGome — system biomarkers of tumor metabolism — then use machine learning to detect signatures of cancer noninvasively.
Learn more
